FindTrial
Sign In

Tamsulosin HCl

DRUG5 trials

Sponsors

Astellas Pharma Europe B.V., Boehringer Ingelheim

Conditions

Benign Prostatic HyperplasiaDrug-Drug Interaction (DDI)HealthyHealthy SubjectsLower Urinary Tract SymptomsPharmacokineticsPhase 1Prostatic Hyperplasia

Phase 1

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects
CompletedNCT02169713
Astellas Pharma Europe B.V.Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics
Start: 2014-05-31End: 2014-08-31Updated: 2014-08-29
Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers
CompletedNCT02264171
Boehringer IngelheimHealthy
Start: 2008-04-30Updated: 2014-10-15
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.
CompletedNCT02417844
Boehringer IngelheimProstatic Hyperplasia
Start: 2015-04-30End: 2015-05-31Updated: 2020-04-17
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.
CompletedNCT02417831
Boehringer IngelheimProstatic Hyperplasia
Start: 2015-04-30End: 2015-05-31Updated: 2020-04-27
EC905 Pharmacokinetic Profile Study
CompletedNCT02634489
Astellas Pharma Europe B.V.Benign Prostatic Hyperplasia, Healthy, Lower Urinary Tract Symptoms +1
Start: 2009-03-31End: 2009-07-31Updated: 2015-12-18